Position in ANIP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,152
+$999 QoQ
Shares Held
26
+73.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#278
of 303 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $7,829,403 across 8 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
223,068 | $7,733,767 | |
| 2 | HLN |
Haleon plc
|
5,397 | $50,354 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,228 | $41,604 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
This page
|
26 | $2,152 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
24 | $608 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
10 | $410 | |
| 7 | ZTS |
Zoetis Inc.
|
4 | $287 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
11 | $221 |
All Filings in ANIP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,152 | 26 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,153 | 15 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,025 | 51 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,957 | 30 | Shares | Sole | 2025-08-11 | |
| 2024-12-31 | $110 | 2 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $13,781 | 231 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||